This part is super important
"Further to the recent equity placement announcements made on 10 November 2015 of $600,000 and 20 November 2015 of $1,400,000, the company confirms that all shares due to be issued as part of the consideration for the recent placements will not be quoted until after completion of forthcoming prospectus in relation to the acquisition of Xped Holdings Limited. The restrictions imposed on the shares again highlights the Company’s direction of attracting key strategic investors."
- Forums
- ASX - By Stock
- RYG
- Ann: Xped Receives Key Granted Patent
Ann: Xped Receives Key Granted Patent, page-8
-
-
- There are more pages in this discussion • 302 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
Add RYG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online